Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. articles
  3. biopharma
Show results for

Refine by
Date

  • This Year

Biopharma Articles & Analysis: This-Year

7 articles found

Recombinant Protein Expression Service in CHO Cells

Recombinant Protein Expression Service in CHO Cells

Recombinant protein expression is a cornerstone of modern biopharmaceutical development, providing the means to produce proteins with therapeutic potential, enzymes, and antibodies. Among various expression systems, Chinese Hamster Ovary (CHO) cells have emerged as the preferred choice for many researchers and pharmaceutical companies. This article delves into the significance of recombinant ...

ByCreative Biogene


CHO Cell Antibody Drug Production Service: A Revolutionary Approach

CHO Cell Antibody Drug Production Service: A Revolutionary Approach

In the ever-evolving field of biopharmaceuticals, the production of antibodies has taken center stage due to their critical role in therapeutic applications. Among the various production systems available, Chinese Hamster Ovary (CHO) cells have emerged as a gold standard for monoclonal antibody production, and specialized services have been developed to streamline this process. The Significance ...

ByCreative Biogene


Monodispersed PEG Linkers Enhance Antibody–Drug Conjugates (ADCs)

Monodispersed PEG Linkers Enhance Antibody–Drug Conjugates (ADCs)

Studies show that well-defined PEGylated drugs can overcome the immunogenicity and adverse effects associated with polydisperse PEG mixtures. or example, anti-PEG antibody levels rise with widespread use of conventional PEG, but discrete PEG linkers can mitigate this “ABC” effect. Biopharma PEG (Watertown, MA) offers a range of monodisperse PEG linkers specifically ...

ByBiopharma PEG Scientific Inc


PEGylation in Pharmaceutical Development: Enhancing Drug Efficacy and Safety

PEGylation in Pharmaceutical Development: Enhancing Drug Efficacy and Safety

Introduction PEGylation, the process of attaching polyethylene glycol (PEG) chains to therapeutic molecules, has become a cornerstone in pharmaceutical development. This technique improves the pharmacokinetic and pharmacodynamic properties of drugs, enhancing their stability, solubility, and circulation time while reducing immunogenicity. Since its first FDA-approved application in 1990 with ...

ByBOC Sciences


Innovative Preclinical Alfa Cytology alfaCAR-T Solutions: Revolutionizing the CAR-T Development Platform

Innovative Preclinical Alfa Cytology alfaCAR-T Solutions: Revolutionizing the CAR-T Development Platform

Cancer treatment has witnessed transformative advancements over the past few decades, notably with the emergence of CAR-T (Chimeric Antigen Receptor T-cell) therapy. This revolutionary therapy harnesses the body's immune system by genetically engineering T-cells to target and destroy cancer cells. Among the pioneering companies at the forefront of this innovation is Alfa Cytology, renowned for ...

ByAlfa Cytology


BIOPHARMA PEG Showcases DSPE-PEG-Mannose: A Cutting-Edge Polymer for Drug Delivery and Biomedical Applications

BIOPHARMA PEG Showcases DSPE-PEG-Mannose: A Cutting-Edge Polymer for Drug Delivery and Biomedical Applications

Watertown, MA – March 24, 2025 – Biopharma PEG, a leading supplier of high-quality polyethylene glycol (PEG) derivatives, highlights its innovative product DSPE-PEG-Mannose, an advanced biomedical polymer with significant potential in drug delivery, tumor-targeted therapy, tissue recognition, and adhesion.Structural Advantages of DSPE-PEG-MannoseDSPE-PEG-Mannose is composed of ...

ByBiopharma PEG Scientific Inc


GMP Cell Bank Characterization: Ensuring Quality and Safety in Biopharmaceuticals

GMP Cell Bank Characterization: Ensuring Quality and Safety in Biopharmaceuticals

Introduction Good Manufacturing Practice (GMP) cell banks play a crucial role in the biopharmaceutical industry, serving as foundational repositories of cell lines used for the production of therapeutic biological products. Characterization of these cell banks is essential to ensure the safety, efficacy, and consistency of the biopharmaceuticals derived from them. This article will explore the ...

ByCreative Bioarray

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT